<DOC>
	<DOCNO>NCT01127321</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability MEDI-570 adult subject moderately severely active systemic lupus erythematosus ( SLE ) .</brief_summary>
	<brief_title>A Safety Tolerability Study MEDI-570 Systemic Lupus Erythematosus</brief_title>
	<detailed_description>This Phase 1 , double-blind , randomize , placebo-controlled study evaluate safety tolerability escalate single subcutaneous dos MEDI-570 adult subject moderately severely active SLE .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>Meet meet least 4 11 revised American College Rheumatology ( ACR ) classification criterion systemic lupus erythematosus ( SLE ) Score great equal ( &gt; = ) 6 point Systemic Lupus Erythematosus Disease Activity Index 2000 ( SLEDAI2K ) Screening Ability complete study period , include followup period Day 169 Willingness forego form experimental treatment study . History cancer except basal cell carcinoma treat apparent success curative therapy &gt; =1 year randomization study Evidence active latent tuberculosis ( TB ) History primary immunodeficiency Evidence infection time hepatitis B C virus human immunodeficiency virus ( HIV ) 1 HIV2 , active infection hepatitis A , determined result test Screening History sepsis serious , recurrent , chronic infection , current sign symptom clinically significant chronic infection , recent ( within 6 month Baseline visit ) serious infection Any history evidence opportunistic infection within 6 month Screening include severe cytomegalovirus ( CMV ) herpetic infection ( disseminated herpes , herpes encephalitis , ophthalmic herpes ) Receipt cyclophosphamide ( intravenous oral ) within 6 month Screening Have absolute contraindication skin punch biopsy , example , history coagulation disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Systemic lupus erythematosus</keyword>
	<keyword>SLE</keyword>
	<keyword>MEDI-570</keyword>
</DOC>